PolyPeptide draws takeover interest from EQT and KKR
Swiss contract development and manufacturing company PolyPeptide Group AG is attracting potential acquisition interest from several private equity firms, including EQT AB and KKR & Co, according to a Bloomberg News report citing unnamed people familiar with the discussions.
Original Source
Read the full article at Privateequitywire →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.